Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,833.44
    -43.61 (-0.55%)
     

  • Bitcoin USD

    64,945.18
    +2,603.97 (+4.18%)
     

  • CMC Crypto 200

    1,331.44
    +18.81 (+1.43%)
     

  • S&P 500

    5,004.35
    -6.77 (-0.14%)
     

  • Dow

    37,884.40
    +109.02 (+0.29%)
     

  • Nasdaq

    15,514.28
    -87.22 (-0.56%)
     

  • Gold

    2,396.60
    -1.40 (-0.06%)
     

  • Crude Oil

    82.56
    -0.17 (-0.21%)
     

  • 10-Yr Bond

    4.6100
    -0.0370 (-0.80%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Catalyst Pharmaceutical (CPRX) Jumps: Stock Up 9%

Zacks Equity Research

Catalyst Pharmaceutical Partners Inc. (CPRX) was a big mover last session, as its shares rose nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up almost 54% in the past one-month timeframe.

In the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Catalyst Pharmaceutical Partners currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the med-drugs industry include Endo International plc (ENDP), Hyperion Therapeutics, Inc. (HPTX) and Lannett Company, Inc. (LCI). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



CATALYST PHARMACEUTICAL PARTNERS (CPRX): Free Stock Analysis Report

ENDO INTERNATIONAL PLC ORD (ENDP): Free Stock Analysis Report

LANNETT COMP (LCI): Free Stock Analysis Report

HYPERION THERAPEUTICS INC (HPTX): Free Stock Analysis Report


Zacks Investment Research